67Cu-based TraceNET therapeutic (NUCLIDIUM)

N/A

Report date: 2025/09/11 14:21:06
NME

Base Information

Drug Name67Cu-based TraceNET therapeutic (NUCLIDIUM)
Drug Alias Name67Cu-based TraceNET™ therapeutic (NUCLIDIUM)
ClassificationSmall moleculesRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Copper > 67Cu +[4] 
Mechanisms of ActionIonising radiation emitters
TargetsUpdating
Therapy Area/IndicationsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNuclidium AG
China Registration ClassN/A

Develop Information

Active CompaniesNuclidium AG
Inactive CompaniesN/A
Active IndicationsNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A